Malaria Vaccines

Research for development of a malaria vaccine is currently underway to find an effective modality to control and eliminate the transmission of malaria. To date, no vaccine has been found to be efficacious in fighting against malaria. Here is the latest research on malaria vaccines.

January 14, 2021
Review
Open Access

Genus Parkia : Phytochemical, Medicinal Uses, and Pharmacological Properties

International Journal of Molecular Sciences
Mohammed S M SalehYusof Kamisah
January 15, 2021

A comprehensive review on the biological interest of quinoline and its derivatives

Bioorganic & Medicinal Chemistry
Basavarajaiah Suliphuldevara MatadaNagesh Gunavanthrao Yernale
January 13, 2021

A Diverse Range of Hemozoin Inhibiting Scaffolds Act on Plasmodium falciparum as Heme Complexes

ACS Infectious Diseases
Roxanne OpenshawTimothy J Egan
January 15, 2021
Preprint
Open Access

Bulk Segregant Approaches to Nutritional Genomics in Plasmodium falciparum

ResearchSquare
SUDHIR KUMARTimothy Anderson
January 17, 2021
Open Access

Functional Characterization and Comparison of Plasmodium falciparum Proteins as Targets of Transmission-blocking Antibodies

Molecular & Cellular Proteomics : MCP
Daria NikolaevaSumi Biswas
January 15, 2021
Preprint
Open Access

High prevalence of Plasmodium malariae and Plasmodium ovale in co-infections with Plasmodium falciparum in asymptomatic malaria parasite carriers in Southwest Nigeria

MedRxiv : the Preprint Server for Health Sciences
M. A. AbdulraheemRichard Culleton
December 24, 2020
Open Access

Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor's Perspective

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Elena BeyzarovPatrick Caubel
January 19, 2021

Interaction of artemisinin protects the activity of antioxidant enzyme catalase: A biophysical study

International Journal of Biological Macromolecules
Rashmi R SamalUmakanta Subudhi
January 20, 2021
Open Access

Development and Clinical Validation of Iso-IMRS: A Novel Diagnostic Assay for P. falciparum Malaria

Analytical Chemistry
Nikunja KolluriCatherine M Klapperich
January 20, 2021

Bisindole alkaloids from Voacanga grandifolia leaves

Journal of Natural Medicines
Alfarius Eko NugrohoHiroshi Morita
January 20, 2021
Open Access

Identification of a neutralizing epitope within minor repeat region of Plasmodium falciparum CS protein

NPJ Vaccines
J Mauricio Calvo-CalleElizabeth Nardin
January 13, 2021
Open Access

Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box

Nature Communications
Janette ReaderLyn-Marie Birkholtz

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Amoebiasis

Amoebiasis, infection by the protozoan parasite Entamoeba histolytica, remains a global health problem, despite the availability of effective treatment. Here is the latest research.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

© 2021 Meta ULC. All rights reserved
/feed-previews/malaria-vaccines/44aa4521-a27f-417a-8746-5185b6dc399b